Should Metformin Continue as First-Line Pharmacotherapy for Patients With Type 2 Diabetes? Yes: Metformin Is Still the Best Choice

Am Fam Physician. 2024 Mar;109(3):200-201.
No abstract available

MeSH terms

  • Diabetes Mellitus, Type 2* / drug therapy
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Metformin* / therapeutic use
  • Patients
  • Sulfonylurea Compounds / therapeutic use

Substances

  • Metformin
  • Hypoglycemic Agents
  • Sulfonylurea Compounds